Jenburkt Pharmaceuticals Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 50.57 | 37.03 | 48.98 |
| Operating Expense | 35.30 | 29.49 | 34.33 |
| Net Profit | 10.21 | 5.89 | 10.85 |
| Net Profit Margin | 20.19% | 15.91% | 22.15% |
| Earning Per Share | 23.13 | 13.34 | 24.58 |
| EBIDTA | 14.64 | 7.66 | 15.43 |
| Effective Tax Rate | 22.92% | 13.26% | 24.85% |
Particulars
Sep 2026
Revenue50.57
Operating Expense35.30
Net Profit10.21
Net Profit Margin20.19
Earning Per Share23.13
EBIDTA14.64
Effective Tax Rate22.92
